Back
Equity Residential Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
67
EQR
Equity Residential
Last Price:
67.51
Seasonality Move:
2.1%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
42.57
Seasonality Move:
12.29%
Buy
67
Equity Residential (EQR)
is a Buy
Is Equity Residential a Buy, Sell or Hold?
- The current Equity Residential [EQR] share price is $67.57. The Score for EQR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- EQR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EQR Stock Price Chart
What is Equity Residential's stock price today?
-
The Equity Residential share price today is $67.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EQR is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
EQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 67.34 | Buy |
Chaikin Money Flow: | -891021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.94 - 66.72) | Buy |
Bollinger Bands (100): | (59.63 - 64.13) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.38 | Sell |
Relative Strength Index (14 RSI): | 36.17 | Sell |
Chaikin Money Flow: | -526969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.16 - 45.34) | Sell |
Bollinger Bands (100): | (43.31 - 49.39) | Sell |
EQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.88 | Buy |
20-day SMA: | 65.15 | Buy |
50-day SMA: | 63.41 | Buy |
200-day SMA: | 60.95 | Buy |
8-day EMA: | 66.75 | Buy |
20-day EMA: | 65.46 | Buy |
50-day EMA: | 63.7 | Buy |
200-day EMA: | 62.02 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.46 | Sell |
20-day SMA: | 42.72 | Sell |
50-day SMA: | 45.61 | Sell |
200-day SMA: | 42.06 | Sell |
8-day EMA: | 41.51 | Sell |
20-day EMA: | 42.79 | Sell |
50-day EMA: | 44.59 | Sell |
200-day EMA: | 44.26 | Sell |
Equity Residential Earnings Growth & EQR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.06 per share, and an increase next year of $0.07 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Equity Residential Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |